Lipe & Dalton’s Colgate-Palmolive CL Stock Holding History

Lipe & Dalton’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	-$29K	–	105
2019 Q3	$29K	Hold	400	–	–	0.02%	97
2019 Q2	$29K	Buy	+400	New	+$28.4K	0.02%	91

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lipe & Dalton's CL Position: Q4 2019 in Review

Lipe & Dalton sold out of Colgate-Palmolive (CL) in Q4 2019, closing a stake of 400 shares — an estimated $29K sold.

Lipe & Dalton first reported a position in CL in Q2 2019 and held it in 2 quarters. The position peaked at $29K in Q3 2019. 1,509 funds tracked by Wall St. Rank hold CL as of Q4 2019.

Lipe & Dalton reported no remaining Colgate-Palmolive position as of Q4 2019 after selling out during the quarter.
Lipe & Dalton sold 400 Colgate-Palmolive shares in Q4 2019, an estimated $29K.
Lipe & Dalton first reported a position in Colgate-Palmolive in Q2 2019 and held it in 2 quarters.
Lipe & Dalton's Colgate-Palmolive position peaked at $29K in Q3 2019.
1,509 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2019.

Based on Lipe & Dalton's 13F filing for Q4 2019, filed 21 Jan 2020.